Access to clinical cancer genomics and precision oncology-based care in North America.
A major review documents why precision cancer genomics often fails to reach patients despite scientific readiness, proposing a practical North American implementation roadmap.
Lancet Americas review from MSK, Princess Margaret, Mayo Clinic, and 18 other institutions documents systematic failure of precision oncology implementation at four operational steps despite adequate scientific and technical capacity in North America. The proposal of a tri-national implementation agenda is timely given rapid AI deployment in genomic decision-making, with open-access PMC publication enabling broad circulation.
What the study was
- Study design
- Narrative synthesis / review
- Category
- Precision oncology and genomic medicine
- Maturity
- Validated
- Journal
- Lancet Reg Health Am
Why it surfaced
Lancet Regional Health Americas; multi-institutional authorship spanning MSK, Princess Margaret, Mayo Clinic; rare North America-spanning view of precision oncology equity; direct policy relevance for reimbursement, access, and guideline development. PMC open access.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.